Jayant S. Kulkarni Ph.D. (Wayne State Univer8lly USA) and post-doctoral research at Yale University and Karmanos cancer Foundation USA has more than seven years of experience in R&D. He has also worked as Assistant Professor in a pharmacy Currently he is working as a Research Scientist at Reliance Life Sciences Mumbai. He has published 14 research articles in international and has presented his research work at various international national conferences.
<div class="short-description" style="margin: 10px 0px; padding: 0px; color: rgb(33, 37, 41); font-family: system-ui, -apple-system, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", "Liberation Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji"; letter-spacing: 0.7px;"><div class="std" style="margin: 0px; padding: 0px;"><p style="margin-right: 0px; margin-bottom: 6px; margin-left: 0px; padding: 0px; text-align: justify;">Biopharmaceutics and Pharmacokinetics deals with what body does to the drug. In this book along with the fundamentals of absorption distribution metabolism and excretion current topics such as in vitro systems have also been introduced.</p><div><div id="product_tabs_description_tabbed_contents" style="margin: 0px; padding: 0px; letter-spacing: 0.7px;"><ol style="margin-right: 0px; margin-bottom: 10px; margin-left: 0px; padding: 15px 0px; list-style: none;"><div class="std" style="margin: 0px; padding: 0px;"><p style="margin-right: 0px; margin-bottom: 6px; margin-left: 0px; padding: 0px; text-align: justify;">In case of Pharmacokinetic Models authors have tried to keep mathematical part simpler and minimal. This book also introduces Non-compartmental models which are gaining increasing importance in the analysis of pharmacokinetic data. In the chapter Applications of Pharmacokinetics newer concepts such as chronopharmacokinetics have been introduced. Bioequivalence is covered in last two chapters. Besides clinical aspect of bioequivalence some of the important aspects of bioanalysis have also been introduced. The regulatory aspect of bioequivalence has also been covered. Thus an attempt has been made to cover all the basic aspects of biopharmaceutics and pharmacokinetics in a reader-friendly manner.</p></div><div class="std" style="margin: 0px; padding: 0px;"><div><br></div></div></ol></div><div id="product_tabs_additional_tabbed_contents" style="margin: 0px; padding: 0px; display: none; letter-spacing: 0.7px;"></div></div></div></div>
